Baran M, Cakir M, Yüksekkaya H A, Arikan C, Aydin U, Aydogdu S, Kilic M
Department of Pediatric Gastroenterology Hepatology and Nutrition, Ege University, Izmir, Turkey.
Transplant Proc. 2008 Jan-Feb;40(1):320-1. doi: 10.1016/j.transproceed.2007.11.056.
Chylous ascites are the accumulation of chylomicron-rich lymphatic fluid within the peritoneal cavity, resulting from obstruction or disruption of abdominal lymphatic channels. This rare condition may be associated with neoplastic or infectious infiltration of lymphatics, with pancreatitis, and with abdominal surgery. It may occur spontaneously in 0.5% of patients with cirrhosis; but only among a few liver transplantation cases. The management of chylous ascites is controversial; the variety of described treatments include repeated paracentesis, dietary control, peritoneovenous shunting, and surgical ligation of the disrupted lymphatic channels. In this article, we report 2 cases of rapid resolution of chylous ascites after liver transplantation following 5 days of treatment using a somatostatin analog and total parenteral nutrition (TPN). A 3.5-year-old girl and a 5-year-old girl underwent living related liver transplantation for biliary atresia and hepatoblastoma, respectively. Chylous ascites, diagnosed by ascitic fluid examination, developed within the 2 weeks after transplantation in the 2 cases. Treatment by fasting, TPN, and somatostatin analog resulted in rapid resolution of the ascites within 1 week. The prevalence of chylous ascites was noted in 1.6% of children (2/119) after liver transplantation. These cases highlight the use of somatostatin analog and parenteral nutrition in chylous ascites after liver transplantation.
乳糜性腹水是腹腔内富含乳糜微粒的淋巴液积聚,由腹部淋巴管道阻塞或破坏引起。这种罕见病症可能与淋巴管的肿瘤性或感染性浸润、胰腺炎以及腹部手术有关。它可能在0.5%的肝硬化患者中自发出现;但仅在少数肝移植病例中发生。乳糜性腹水的治疗存在争议;所描述的治疗方法包括反复腹腔穿刺放液、饮食控制、腹腔静脉分流术以及对破裂淋巴管道进行手术结扎。在本文中,我们报告了2例肝移植后乳糜性腹水在使用生长抑素类似物和全胃肠外营养(TPN)治疗5天后迅速消退的病例。一名3.5岁女孩和一名5岁女孩分别因胆道闭锁和肝母细胞瘤接受了活体亲属供肝肝移植。通过腹水检查确诊的乳糜性腹水在这2例患者移植后的2周内出现。禁食、TPN和生长抑素类似物治疗使腹水在1周内迅速消退。肝移植后儿童乳糜性腹水的发生率为1.6%(2/119)。这些病例突出了生长抑素类似物和肠外营养在肝移植后乳糜性腹水中的应用。